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For many years the leptospiroses were considered rare diseases and
until only a few years ago, they were unrecognized in livestock in the
United States. It is now well established that they occur in man and his
domestic animals throughout the world and constitute a major problem in
certain animals. Leptospiral infections are zoonoses. The infection is
transmissible from animal to animal (6) (8) and from animals to humans (46).
The past decade in this country has seen an increasing awareness of the
prevalence of leptospirosis in man, the domestic animals and the wild life.
The public health and livestock sanitary problems posed by these infections
and their economic significance to the livestock industry are increasingly
appreciated (45). Clinical experience coupled with serological surveys in
many parts of the United States indicate that at least 20 to 25 per cent of
the swine (129) and 5 to 50 per cent of the cattle (92) have experienced
infection with leptospira Pomona, h morbidity rate of SO per cent is a
common finding for an outbreak in cattle or swine (77).
Therefore, tremendous annual economic losses are incurred in dairy and
beef cattle as a result of abortion, decreased lactation, stunting of young
growing stock and death (65). It has also been recognized that the disease
possesses a very serious explosive potential at all times, and it appears
that the disease is on the increase and widespread at the present time.
United States Department of Agriculture in its review "Losses in Agriculture,
1954" (65) has estimated an annual loss in cattle alone amounting to as much
as 1112,282,000 to the above causes. The severity of the problem will be
more apparent, if similar losses in swine and other domestic animals are
estimated, and the potential public health hazards are considered. This
has resulted in an ever-increasing demand for continued inquiry and research.
This inquiry into the problems of epidemiology, diagnosis treatment and pro-
phylaxis brought out additional information from time to time, along with
many points of disagreement among various workers. In the field of pro-
phylaxis, a number of control programs have been advocated and initiated.
Besides, numerous commercial bacterins for the active immunization of cattle
and swine to prevent the spread of infection in natural outbreaks of the
disease have come into existence. These bacterins are extensively used at
the present time in the field with claims and counter-claims on their ability
to produce satisfactory immunity in cattle.
Studies of bio-prophylaxis of leptospirosis has always been a contro-
versial subject, ever since such results have been reported by Inado et al.
in 1916 (54) • However, the commercial bacterins now available for active
immunization have all been claimed to produce satisfactory immunity against
natural outbreaks in cattle. A critical evaluation of many such reports
always disclosed some serious difficulties in proof and stimulated further
research. In addition to these doubts, field experiences have failed to
convince the research worker. Consequently this study was undertaken to
evaluate the immunological response of a widely used commercial leptospira
pomona bacterin in laboratory animals*
REVIEW OF LITERATURE
Pathogenic leptospires were isolated first from cases of Weil's
disease in 1915 independently by Inado et al. (54) in Japan, Hubner and
Reiter (52) in Germany, and Uhlenhuth and Fromme (116) also in Germany.
Earlier in 1886, Weil (124) described several cases of "leptospirosis" in
humans, although he had no knowledge of the causative agent. Nearly twenty
years later, leptospires were first seen in New Orleans by Stimson (105)
in sections of kidney from a patient believed to have died of yellow fever.
In 1935, translations appeared concerning Russian findings by Semskow and
fellow workers (101) of a spirochete (they) called Leptospira Icterohaemo-
globinurea in calves and man. Leptospira Pomona was first recognized in
1937 by Clayton et al. (27) as the cause of illness in a dairy farmer in
Pomona, Australia. This was followed by studies in Palestine by Freund,
Bernkopf and others (34) (8), concerning a similar organism called Leptospira
Bovis that caused disease in cattle and was considered fatal to man.
In the United States, Jungherr (60) from Connecticut in 1937 reported
his finding leptospires in the kidneys of three different cattle at autopsy.
Marsh (67) in 1945 and Mathews (69) from Texas have reported similar find-
ings. Shortly thereafter, Baker and Little (4) in 1948 published a complete
report of leptospirosis in cattle. These workers isolated the organism
from a febrile disease in a dairy cow in New Jersey, which they earlier
considered as a filterable virus. They soon realized however, from their
continued research, that the original agent they had isolated from the milk
of the cow and transferred successfully to other cattle, guinea pigs, mice,
hamsters and fertile eggs, was actually the leptospira. Following this
initial report, the disease has been found to exist in many other parts of
the United States. The organism however, could not be classified immediately
until extensive comparative serological tests necessary could be developed.
Bernkopf and Little (7) in 1948 proved by serologic tests that the American
strain of leptospira was different from the more virulent one found in
Palestine. Finally Gochenour et al. (44) in 1950 found antigenic similarity
between the bovine leptospira in the United States and the one in Australia
that had been called Leptospira Pomona.
Thus, leptospirosis is now recognized aa an apparently widespread
infectious disease of cattle, swine, sheep and horses usually caused by
Leptospira Pomona and of dogs caused by Leptospira Canicola (119). Occa-
sionally leptospira Canicola has been reported from bovine cases. The
disease is characterized by fever, marked prostration, icterus, hemo-
globinuria, bloody milk in the severe form, depression, inappetence and
a drop in the milk production in the chronic form (71).
With the result, extensive studies have been carried out by various
workers on the epidemiology, pathology, immunology and control of this
disease during the past few years.
Epidemiology
Epidemiologically, it has been brought out by several workers (72)
(118) (46) (57) that leptospirosis is primarily a disease of rodents and
it is upon these hosts that the leptospires depend for their survival, and
that man and the domestic animals become infected by coming in contact with
excreted leptospires. Experimental work conducted in a search to determine
the natural reservoir host for Leptospira Pomona among the domestic animals
besides the rodents, indicate swine as the natural reservoir host. It was
thought that infection in cattle did not appear to be as widespread as it
does in swine. Furthermore Leptospira Pomona transferred readily by con-
tact exposure from pig to pig and from pig to cattle, a finding apparently
made possible by the tremendous numbers of organisms eliminated in the
urine over long periods in carrier swine. Although rodents and swine are
considered to be the primary animal carriers, recent investigations have
revealed a variety of hitherto unrecognized wild mammal hosts (1) (119).
Present studies seem to indicate additional sylvatic leptospiral carriers
in many parts of the world (3). It has also been confirmed that these
organisms display an affinity for the renal cortex and may be found nest-
ing in the lumina of the convoluted tubules of the kidneys of clinically
recovered animals and in others with an inapparent infection (3). They
may be shed in the urine of these carrier animals for varying periods of
time. It is not very clear why certain animals become permanent carriers,
while in others the urinary elimination of leptospires is only a transi-
tory event. The present knowledge with regard to the exact epidemiological
significance of each species in any outbreak of this disease is also not
complete. However the epidemiology of infection seems to be governed to
a great extent by the availability of suitable hosts and an external en-
vironment favorable to the survival of leptospires.
Diagnosis
Varyinus methods of diagnosis of the disease are available at present,
though many are cumbersome and some are of doubtful value. It is essential
in establishing a definite diagnosis that the clinical findings be con-
firmed not only by the serological evidence but should be supported by the
isolation and demonstration of the organism, followed by animal inoculation
procedures to determine the virulence of the organism (isolated) and its
capacity to produce pathological changes in experimental animals. In
essence, Koch's postulates should be established, for, many times clinical
symptoms are inadequate and the value of serological tests are confusing.
Serologically, the test of classical significance is the agglutination-
lysis test of Schuffner and Mochtar (100), one of the earliest leptospiral
sero-diagnostic tests devised. It has been, and is today, the most widely
used procedure in this respect. This is a microscopic agglutination test
in which living leptospires are employed as antigens. This is also
considered a standard procedure against which all other serological
methods devised later have generally been evaluated. Recently, comple-
ment fixation test and a capillary tube agglutination test have been de-
scribed. In many such procedures killed organisms as antigens have been
used. Randall et al. (87) have employed leptospires subjected to sonic
vibration as antigen in the complement fixation test, and claimed positive
reactions from serums taken as early as fifth day of illness. York (127)
devised a complement fixation test in which formalinized infected chorio-
allantoic fluid is used as antigen. The agglutination test devised by
Stoenner (109) is performed by formalin killed concentrated antigen.
Thus various serodiagnostic technics have been developed and perfected,
but at present, the value of any serological test, however, is limited to
a considerable extent by the presence of various serotypes of the organism
and many nonspecific reactions encountered in these procedures. Clinically
it has been observed that leptospirosis is one of the most variable dis-
eases ever studied. Even in a single herd under close observation, all
animals do not show exactly the same degree of illness which may vary all
the way from inapparent infection to death. Isolation of the organism
from blood, urine and other sources, identifying the organism, and demon-
stration of its pathogenicity in suitable animals therefore is the only
way to establish a diagnosis. Isolation of the organism again is by no
means easy to accomplish. Leptospires, unlike many other bacteria, are
not visible v.ith ordinary staining methods and by the usual microscopic
examination. They would not or could not be seen unless they are spe-
cifically searched for with suitable equipment from any of the body fluids.
They do not grow and multiply in the usual bacteriological media under
ordinary laboratory conditions. Some of these variabilities of lepto-
spirosis as a disease and the peculiarities of leptospira as an organism,
makes it all the more difficult to isolate and establish the organism lor
appropriate tests. However, bacteriological evidence has to be established
by animal inoculation and culture methods in support of clinical and sero-
logical evidence in view of the present inadequate serological techniques.
This is particularly essential if knowledge oi' the epidemiology is to be
obtained and a specific prophylaxis and control program is to be instituted.
Prophylaxis and Management
With mounting evidence as to the economic significance of the disease
in domestic animals, it is only natural that various prophylactic programs
should have been initiated. Prevention and control of leptospirosis as in
the case of any other infectious disease depends to a large extent on the
background of information available on the various aspects of the disease
accumulated by a number of research workers. Factors such as the ecology
of the carrier host, the carrier state in the recovered animals or in the
inapparent infections, the mode of transmission of the disease, the number
of susceptible animals in an outbreak and the conditions peculiar to each
outbreak, should be taken into consideration in planiiing any control program.
It was shown experimentally that infection could occur by contact exposure
between susceptible animals. Baker and Little (4) have observed that in-
fection could also occur by infected urine excreted by a standing animal
onto the concrete floor of a barn thereby causing a spread of droplets to
arise, which in turn are inhaled by nearby healthy animals. Organisms can
also gain entrance through conjunctiva in such a case. This mode of in-
fection could explain how a single carrier animal whether pig or cow could
8initiate infection in a susceptible herd of cattle. Spread of infection
from one farm to the other could easily occur by the contamination of a
connecting water source by infected urine. The severity of an outbreak
in any case largely depends on the virulence of the infective agent and
the number of susceptible animals in an infected herd.
Active campaigns for the destruction or elimination oi carrier
animals from a herd and appropriate hygienic measures should greatly help
in reducing the incidence of leptospirosis . Jones et al. (58) reported a
successful attempt to control leptospirosis among dogs at the war dog
reception and training c-nter by the total elimination of &n carrier
animals. Each dog was kept in quarantine on arrival for a period of two
weeks, agglutination tests carried out and the dog was destroyed if the
serum reacted positively. Evidently such drastic measures are neither
practicable nor justified when swine are considered as carriers and the
l&rge number of subclinical or inapparent carrier states occur in cattle.
Therapy and management of individual infected animals has received
considerable attention during the past few years. Treatment as in any
other acute or chronic infectious disease depends on the stage of the
disease that might be presented. It should aim at the preservation of
the life of the patient in the acute stage and to prevent or treat car-
riers in chronic stages. Treatment with the available antibiotics may be
mo3t effective in the early stages and of very little value in the carrier
condition. In vitro studies indicate penicillin, streptomycin, aureomycin,
terramycin, and oxytetracyclin as active against leptospires, particularly
the latter two (59). However, results of treatment in actual cases vdth
any one or combination of them are variable. None of them have been
shown conclusively to influence significantly the course of the disease
when administered after hepatic or renal changes have occurred (106).
Thus, in the absence of any effective therapeutic agent, careful atten-
tion to general supportive measures and dietary regulations should be con-
sidered as of paramount importance in the treatment of individual animals.
It is well known that a natural attack of leptospirosis confers a degree
of immunity in man and other animals. Obviously, active immunization of sus-
ceptible cattle in an enzootic area or in an infected herd coupled with ap-
propriate hygienic measures, appears to be the logical approach to the control
or elimination of bovine leptospirosis. Since the disease spreads slowly
through a herd of cattle, vaccination to stop spread of Infection might be
looked upon as a form of herd therapy in the control.
Successful active immunization against leptospiral infections was first
reported by Inado et al. (55) in 1916. They immunized guinea pigs with
emulsions made from the livers of infected animals, the organisms being
killed by 0.5 per cent phenol.
Noguchi (81) in 1918 showed that three injections of 0.5 milliliters of
killed leptospiral cultures made guinea pigs completely resistant to both
homologous and heterologous strains of leptospires. He stated when smaller
quantities were given, the immunity established was only often sufficient to
protect the animals against the homologous strain, and not against hetero-
logous strains. Active immunity was found to persist for eight weeks.
Berger et al. (5) in 1923 claimed to have successfully imaiunized guinea
pigs with cultures of leptospira killed by treating them with copper foil.
The vaccination of acute jaundice caused by leptospira Icterohuexoor-
rhagiae was used successfully in field trials in England by Calling and
Okell (28). The vaccine was prepared from the livers of infected guinea
pigs and was claimed to have produced satisfactory immunity.
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Wani (121) in 1933 reported very successful results from the large
scale immunization of workers in Japan. He claimed a marked reduction in
the incidence of Weil's disease among coal miners vaccinated with killed
suspensions of Leptospira Icterohaemorrhagiae.
Smith (102) in 1937 claimed to have set up a solid immunity in guinea
pigs, but stated that the animals later became urinary shedders, after
challenging with virulent cultures. In this experiment, different groups
of guinea pigs were vaccinated with living nonvirulent strains of Leptospira
Canicola and Icterohaemorrhagiae. In the other groups, vaccination was
carried out by treating them with heat-killed, phenolized, formalized or
dettolized vaccines of the same organisms. Among the animals inoculated
with living nonvirulent cultures, no carriers were detected. In the other
groups, protected by killed cultures, carriers of virulent leptospires were
demonstrated after challenge. Again, where formalized emulsions of Lepto-
spira Canicola and living cultures of virulent Leptospira Icterohaemorrhagiae
were employed for vaccination, further evidence of carrier condition was ob-
tained. Thus, immunization with chemically killed culture vaccines of
virulent strains of leptospira were not successful in preventing the carrier
condition. Presumably, he had succeeded in setting up only a partial im-
munity to suppress obvious clinical symptoms and not the carrier condition.
During the last war, Russian workers claimed excellent results in
controlling bovine leptospirosis in Ukrain and Crimea by successful vaccina-
tion.
On the other hand, Olitzke et al. (82) in 1949 have conducted immuniza-
tion experiments in calves with formalized cultures of Leptospira Bovis.
Their experiments revealed that the formalized leptospires produced only a
moderate but not a solid immunity. They concluded that formalized leptospires
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were devoid of antigen which was believed to be present in the living
organisms, or that the formalized cultures did not contain the amount of
antigen necessary to establish solid immunity. Comparatively better re-
sults, however, were obtained in their experiments by repeated inoculations
by living cultures of the relatively inocuous Gryphotyphosa or treatment
with formalized vaccine followed by inoculation with virulent bovine strain.
In the same year Brunner and Mayer (20) in their efforts to immunize
dogs against Leptospira Icterchaemorrhagiae found that some of the immunized
dogs though apparently healthy proved to be virulent urinary shedders. The
vaccine used by them was prepared by killing the cultures by lyophilization,
and concentrated by high-speed centrifugation. This procedure, they be-
lieved, was not supposed to reduce the antigenicity of the organisms. In
their experiments with guinea pigs immunized with the same vaccine, and
challenged later with virulent living cultures, it was found that though
the guinea pigs were infected, they did not show any apparent symptoms of
infection.
York and Baker (126) and York and Buckner (129) in 1953 in the United
States have published accounts of a method of vaccination for which good
results have been claimed. The vaccine consisted of suspensions of Lepto-
spira Pomona organisms (Cornell strain T262) that had been cultivated in
eggs. They have inactivated the organisms by treating with formalin or by
freezing and thawing. The vaccine was initially tested in calves and guinea
pigs for development of immunity. Two to six weeks after vaccination, ani-
mals were challenged by intraperitoneal inoculation of defibrinated blood
that contained virulent leptospires. The response was evaluated by thermal
reaction and serological tests. They claimed that all the calves and guinea
pigs vaccinated in the experiment developed immunity and resisted challenge,
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while the controls in both groups showed some form of clinical infection.
In field trials where natural infection would occur, it was claimed that
immunity could be produced in a significant number of animals and thus
limit the spread of infection in the vaccinated group.
Similar results were obtained by Brown et al. (17) in their experi-
ments with another bacterin. They have immunized guinea pigs with various
dilutions of bacterin in sterile physiological saline followed by challenge
with virulent organisms. The response was again evaluated by thermal re-
action and serological titration. Further evaluation of the response of
this bacterin was carried out in cattle. A single dose of 5 milliliters of
the bacterin is said to have elicited sufficient serum antibodies to give
an initial positive agglutination lysis test at serum dilutions of 1:10 to
1:250 which was considered sufficiently high to indicate good protection
lasting for a period of one year*
Hoag in 1955 (49) described a soluble immunogenic agent prepared by
the acid heat extraction of living cultures of Leptospira Pomona. The
results of its use indicated that it produces a satisfactory immunity in
calves against infection with homologous strain. Subcutaneous inoculation
of this immunogenic agent seemed to have produced sufficient immunity in
two weeks to resist infection with virulent organisms, whereas the control
animals all developed clinical symptoms, pathological lesions and leptospir-
uria.
Webster and Reynalds in 1955 (123) from New Zealand have also published
satisfactory results of vaccination in guinea pigs and sheep with Leptospira
Pomona bacterin. All the vaccinated animals resisted challenge with 1 milli-
liter of a seven-day old culture of Leptospira Pomona, three weeks after
vaccination and again eleven months later. The criteria of infection was
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thermal reaction, leptoapirurla and differences in weight gains in both
groups. They claimed complete protection of the vaccinated sheep and guinea
pigs against infection.
Vfliile the present study was in progress, Phillips (83) in evaluating
three different leptospiral bacterins concluded that all the products proved
to be exceptionally potent immunogenic agents. In hamsters, protective
immunity could be conferred at a dilution of antigens as high as It 512
against an extremely heavy challenge with Leptospira Pomona. Similar
evaluations were carried out with calves between 600 to 800 pounds. The
calves were seronegetive to agglutination-lysis tests at the beginning of
the experiment. Twenty days after vaccination in three different lots of
calves, all of them including controls were challenged with 2 milliliters
of 10 per cent virulent hamster tissue consisting of liver, kidney and
spleen. The challenge dose was estimated by dark field microscopy to con-
tain 1,000,000 plus hamster M:L.Ds. The results of vaccination were evalu-
ated by thermal reaction and serological tltres. All the controls reacted
to challenge with fever while the vaccinees did not. All the vaccinees
and controls, however, showed a sharp rise in serum titres. In the vaccinees,
there was a gradual but low increase in titres for a period of fifteen days
(recorded) from the lowest prechallenge titre of 1:250 to a low postchallenge
titre of 1:1250. The highest titre obtained was 1:781,250. Similar titres
in controls rose sharply from almost nil to 1:1,000,000.
During the same period Gillespie and Kenzy (38) (39) (37) published
accounts of their evaluation of three different bacterins in calves of
different ages. They have concluded from the results of a series of tests
that:
1. Leptospira Pomona bacterins appear to induce in 6 to 8 month old
uheifers a high degree of immunity which persists for at least 7 to 8 months.
2. Vaccinated cattle that become infected on challenge often appear
to experience a raild form of disease.
3. The vaccination resulted in an apparent reduction of severity of
the disease with suppression of "shedding" even though infection may occur.
4. The calves that received the bacterin when three to five months
of age acquired relatively effective resistance.
They have stated that "Either the appearance of the agglutinins in
high titre or a clearly defined increase (100 fold or more) over the
vaccination titre was found to be reliable criterion of infection in
vaccinated cattle." This procedure supplemented by thermal reaction,
animal inoculations "sometimes" dark field examination of urine, was the
basis for the above experiments. Their results further indicate that the
serum titres six weeks after challenge in the 6 to 8 month old vaccinees
were almost negative, although these animals have resisted challenge. In
one of the vaccinee's in this group, the only indication of infection was
a post challenge titre of 10-4. There was no thermal reaction and the
animal was found to be a urinary shedder. One of the controls showed a
post challenge titre of 10-3. There wao no fever and no evidence of infec-
tion could be detected. From these results it appears that there is no un-
equivocal evidence of protection against infection.
materials and methods
Preliminary work carried out in the laboi-atories of the Pepaitment of
Pathology, Kansas btate University, prior to the beginning of this work
indicated chinchilla (Chinchilla Laniger) as a suitable experimental animal
to leptospiral infections. This prompted further trials in this direction
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with a view to determine the suitability or otherwise of the various
experimental animals available for this -work. Rengen and Okazaki (91)
compared guinea pigs, Syrian hamsters, white nice and two-day old chicks
to their susceptibility to infection vdth Leptospira Pomona. They found
that the guinea pigs and white mice are about equally susceptible, the
hamster significantly more resistant and the chicks highly resistant.
Fisher et al. (33) *nd Howarth and Reina-Guerra (51) have also found that
the chicks are more resistant than hamsters to different species of leptc—
spiral infections. Early experiments in t hi 3 ,*ori: confirmed that the
hamsters and chick embryos are more resistant than guinea pig3 and that the
chinchilla is the least resistant of all to experimental infection vdth
Leptospira Pomona. In hamsters and guinea pigs, intraperitoneal inoculation
of virulent organisms produced only a mild thermal reaction without any ap-
parent clinical symptoms and lasted only several hours, while the same dose
in chinchillas resulted in a prompt thermal reaction, clinical symptoms of
fever followed by death with typical pathological lesions. To date, this
has proved to be the only susceptible animal tested to leptospiral infection,
since in no other animal death could be produced by comparatively larger
doses of organisms. Eighteen chinchillas, 58 guinea pigs, 12 hamsters and a
number of embryonated eggs were used in these trials, "•nile thsse experi-
ments were progressing, Roberts and Turner (93) published similar findings.
Later in this .study, it was found that while death could be produced in
chinchillas with as low as 250 organisms per dose, some of the guinea pigs
may not even sho* thermal reaction with the seme number of organisms.
With these findings in this laboratory and similar experiences of other
workers (93) it was decided to use chinchilla for this study along with guinea
pigs for comparative results.
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Animals
nil the experimental animals in this worK were drawn from the
breeding stock maintained in tne small animal laooratorles ox' this de-
partment. The experiment was carried out in two stages: preliminary and
confirmatory. In the preliminary work, 19 healtny chinchillas of different
ages and 21 young, active guinea pigs weighing between 150 and 290 grams
were selected. One-hall of each species were used as controls. Chinchillas
were kept in small cages, two for each, and tne guinea pigs in large cages,
eleven in each, one of them marked as controls.
In the confirmatory test 24 cninchillas as vaccinees and 8 controls,
12 guinea pigs in each of vaccinees and controls were usea. Body weights
of the guinea pigs were recorded at regular intervals before and after
challenge to observe differences if any in uaiiy weight gains, all tne
experimental animals were Kept under similar conditions throughout the
period and were closely observed daily. Temperatures were recorded and
any animal not appearing normal was replaced oefore eacn experiment was
commenced.
Bacterin
One of the Leptospira Pomoxia bacterin wnich was reported to produce
satisfactory immunity on vaccination in natural outDreaks in the field, was
selected for use in tnis study. Two-tenths (0.2 milliliters; of a minimal
bovine Immunogenic cose of similar vaccines was generally considered adequate
to produce satisfactory immunity against a heavy cnailenge in guinea pigs and
other experimental animals. Dilutions of lil6 to 1:512 of this dose of these
bacUrins »vas reported to have given sufficient immunity in guinea pigs and
hamsters (83). One-fourth part of a recommenced dose for cattle was therefore
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considered adequate to produce the necessary immunity in chinchillas and
guinea pigs in this study. Hence, 0.5 milliliters of the test vaccine was
used for vaccination throughout this study. In the preliminary work, 0.5
milliliters of the vaccine was injected intramuscularly in the gluteal
muscle of the right hind limb of the vaccinees in each group while the
controls were untreated. In the confirmatory test, one half of the same
dose was injected similarly in each limb. In addition, one half of the
vaccinees in this group were given a second injection with the same dose
15 days after the initial vaccination. Temperatures were recorded follow-
ing vaccination and the site of injection was observed for any general or
local reaction.
strain of Leptospira Pomona Used
Leptospira Pomona (Schelecty strain) which was isolated in this
laboratory from the kidneys of a calf diagnosed on necropsy was used in
this study for challenge material. The calf came from nlma, Kansas and
the isolation was made using guinea nigs. The organism was later typed
at the .'alter Reed Army Medical Center, Washington, D. C. The strain has
since been maintained by cultivation in iituart's modified medium (110)
containing 7 to 10 per cent rabbit serum.
Virulence
The virulence of the organism has been maintained by routine passage
through chinchillas. Thus the organism has been through 18 serial passages.
The virulence of the strain at the time of challenge was such that thermal
reaction and clinical symptoms were consistently produced as early as third
day of inoculation resulting in death of the animal by fifth or sixth day
IB
with typical pathological changes in many organs described later. The
organism was recovered from the chinchilla by the cardiac puncture on the
13th passage and cultivated in Stuart's medium and was used for challenge
in the preliminary experiment. The strain was however, passed through
another passage for the second half of the experiment.
Method of Challenge
Normal temperature of all animals was recorded daily starting four
days prior to the day of challenge and continued to completion of the ex-
periment. The animals were inoculated intraperitoneally.
Considering the results of the preliminary study, it was concluded
that the challenge dose was too large to withstand the immunity, if any, and
that the period following vaccination might be too short for the development
of complete immunity. In order to rectify these defects, a method has been
devised to determine the LD-50, and the time between vaccination and challenge
had been increased, and serum samples before vaccination and challenge were
collected and titrated by agglutination lysis tests.
The method followed for the determination of LD-50 was essentially the
same in principle as described by other workers (88) (25), except the number
of animals used in each dose level was limited. A number of media tubes were
inoculated with the organism and incubated at 29° C. for 48 hours. The
cultures were examined by dark field illumination and a culture which did
not show any clumping of organisms was selected. Quantities of 0.0005 milli-
liters of the culture were placed on a clean glass slide by using a micro-
syringe fitted with a 27 gauge needle and were allowed to dry. They were
fixed by gentle application of heat and stained by Fontana's silver method
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(63). Total number of organisms in each quantity was counted under oil-
immersion and the number per milliliter of the original culture was deter-
mined by simple multiplication. The culture was then diluted with stock
medium as to have a known number of organisms per inoculum. A number of
chinchillas were inoculated with graded doses starting from 10,000 to 250
organisms per dose. LD-50 was determined by calculating the number of
organisms which might cause death in 50 per cent of the animals.
Thus, in the second part of the experiment, both the vaccinated and
control animals were challenged with the above dose on the 70th day follow-
ing vaccination.
Following challenge in both experiments, temperatures were recorded
on each day and an average of 3° F. rise in any animal was considered a
thermal reaction. Cultures were made at the initial rise of temperature
from the heart blood. Each animal was anesthetized by ether, and an area
was clipped close of about one inch on the ventral thoracic region anterior
to the xyphoid cartilage. The clipped area was treated with rocal anti-
septic solution. With a 5 milliliter syringe fitted with a 24 gauge needle,
cardiac puncture was made by introducing the needle in between the ribs on
the left lateral aspect nearest to the heart. One milliliter of blood was
drawn, and one to two drops were inoculated aseptically into tubes of
Stuart's modified medium. The tubes were incubated at 29° C. Every effort
was made to prevent contamination during these bleedings. The cultures were
examined on the fifth day of inoculation and at weekly intervals thereafter
for a period of 30 days.
Animals were observed closely following the thermal reaction, clinical
symptoms recorded, and a thorough necropsy was conducted on each animal
immediately after death. Tissues were saved for histopathologic^ studies.
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Criteria of Infection
Clinical symptoms, bacteriological evidence and pathological lesions
were depended upon as evidence of infection in vaccinated as well as
control animals. Agglutination-lysis test wt made use of only in the
determination of immunity following vaccination.
RESULTS
Serological
Serum samples taken from chinchillas and guinea pigs prior to vaccina-
tion and challenge were titrated by agglutination-lysis tests and the re-
sults were tabulated (Tables 7-11). Majority of the samples showed negative
titres both before and after vaccination. Only 10 chinchillas and 8 guinea
pigs gave slight reactions in dilution of 1:10. These results did not
indicate any appreciable increase in serum titres following vaccinption in
chinchillas and guinea pigs.
Clinical
In the preliminary experiment, both vaccinated and control chinchillas
developed thermal reaction following challenge with virulent culture. Clini-
cal signs exhibited are fever, lassitude, depression or weakness, partial
or complete anorexia and occasional bloody diarrhea. Thermal response was
observed on the third or the fourth day of inoculation. There was an average
increase of 3.8° F., the maximum in some animals reaching 104° F. During
this period of pyrexia, the animals were very dull, depressed and did not
eat or drink. They started crouching up in corners, refused to move and
gradually became very weak. (Plates I-II) $r the fifth day, all of them
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appeared very apathetic and took very little interest in their surround-
ings. The temperature became subnormal and they became very weak, lying
down and prostrate. In the next few hours they were moribund and died.
By the sixth day, all the animals were dead (Tables 1-2). Deaths occurred
in the vaccinated animals first and the controls survived longer than in
the vaccinated group. Generally, the thermal reaction did not persist
longer than 36 hours.
All the above symptoms were observed in the confirmatory experiment
with the following additional or modified reactions. Fever began only on
the 4th day in both vaccinees and controls and persisted for the same length
of time. The reaction was not as severe, the maximum recorded temperature
being only 103 .4° F. Deaths occurred only from the 7th day, and in many
animals, the period of survival was much longer. All the vaccinees in the
single dose group, nine in the double dose group and three in the control
group died of the infection. Three in the double treated group and five
in the control group survived infection by the 16th day, and thereafter
continued to live apparently healthy. After this date they started going
down in condition, appeared sick and on the 49th day one in the remaining
three of the double dose vaccinees and another in the control died of the
disease. Thermal reactions and deaths started earlier in the vaccinees
than in the control animals. One hundred per cent of the single dose
vaccinees, 83 per cent in the double dose group and 37 per cent in the
control group died in the acute stage of infection (Tables 12-14).
Differential counts indicate a distinct leucocytosis, the percentage
of neutrophils varying from 58 to 74 per cent and a shift to the left
(Tables 17-18).
In guinea pigs, febrile reaction developed both in vaccinees and
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controls between the fourth and the seventh day of inoculation. Fever
reached a maximum of 106.8 F. in some animals, with an average increase
of 4° F. The febrile period persisted for two to three days in some
animals and then returned to normal. No other clinical evidence of in-
fection was noticeable in these animals (Tables 3-4). All apparently
looked bright and normal in appearance and activity.
Both vaccinees and control guinea pigs were gaining an average of
4.5 grams per day prior to challenge inoculation. Following challenge the
average daily gain per animal had dropped by 0.5 grams for the first ten
days and thereafter, all of them started regaining the average preinocula-
tion gains (Tables 5-6). Throughout the period under observation, the
animals were under similar conditions of feeding and management.
Similar clinical picture in guinea pigs was noticed in the confirma-
tory experiment. Thermal reaction was very mild. Fever appeared only on
the 8th day, reaching a maximum of 105.2° only with an average of 103.3° F.
Five animals in the control group and three in the vaccinees did not show
a temperature response (Tables 15-16). Body weights were not recorded.
Bacteriology
In the preliminary experiment, leptospires were isolated from 8 of 10
vaccinated and 7 of 9 control chinchillas. In guinea pigs, 5 of 10 vac-
cinated and 2 of 11 controls the cultures were positive (Tables 1-4). The
negative results were thought to be due to the use of contaminated serum
in the media.
In the second experiment, 11 of 12 single dose vaccinees, 10 of 12
double dose vaccinees and 7 of 8 control chinchillas gave positive blood
cultures. Two of six double dose vaccinees, three of six single dose
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Taccinees and four of twelve control guinea pigs did not show a thermal
reaction. The rest of the guinea pigs gave positive blood cultures (Tables
12-16).
Pathology
Review of literature . Bovine leptospirosis occurs in an acute
septicemic form or a chronic nephritic form. The septicemic form is
generally hemolytic and fatal. Such cases present generalized icteric
or anemic discoloration of the mucous membranes, hemoglobinuria, and hemo-
globinemia. Petechial hemorrhages may be found on the submucosa or sub-
serosa of many organs and tissues. The liver may be swollen, yellowish or
mottled. The spleen was usually normal in appearance. The kidneys were
of normal color, the stripped surface presenting numerous reddish brown
spots, about 1 to 2 millimeters in size (115). The lungs were normal or
slightly edematous.
Microscopic lesions were consistent in the liver and kidneys, varying
only in the degree among individuals. The kidney changes consisted of
tubular degeneration, cloudy swelling or necrosis and may be distended by
granular debris, protein casts, and leucocytic casts. Thickening of the
Bowman
•
s capsule and congestion qf, the glomerular tufts was reported (89).
Diffuse and focal infiltration of lymphocytes, plasma cells and macrophages
were found throughout the stroma of the renal cortex.
In the liver, disorganization of the hepatic cords, diffuse and focal
infiltration of leucocytes, areas of focal necrosis with cytoplasmic de-
generation and occasional hemosiderosis were reported. Hemorrhagic foci
and ulcerations in the abomssal mucosa were observed (115). Occasionally,
pericorpuscular congestion and hemosiderosis in the spleen were reported.
Lungs were not involved in most of the cases.
In chronic cases, the lesions consisted of focal interstitial
nephritis characterized by infiltration of large masses of lymphocytes
in the cortical stroma.
Present Study. Gross and microscopic changes observed in both groups
of experimental animals were very similar. Of the total chinchillas in
both experiments, 34.3 per cent died in the acute stage. Two guinea pigs
from eacn experiment were sacrificed on the 179th day for observations.
In chinchillas, characteristic gross lesions were jaundice, petechial
and or ecchymotic hemorrhages in most of the organs and tissues, enlarged
liver, hemorrhages and free blood in the stomach and gastroenteritis. In
addition, the lungs and psoas muscles presented many ecchymotic and large
hemorrhages.
Jaundice. Jaundice varied from mild to severe according to the period
of survival of the animals. This condition was observed in 17 of the 44
chinchillas evidenced by the icteric discoloration of the subcutaneous
tissues, peritoneum and liver. The serum collected at the time of death
was typically yellowish in color.
Hemorrhages. Petechial and ecchymotic hemorrhages in the tissues and
organs were present in all the animals that died during the acute stage.
These hemorrhages were observed in the serous surfaces, visceral pleura and
occasionally on the mucous membranes of the stomach and intestines. In the
majority of the animals, the surface of the lungs was studded with hemorr-
hages. In the rest of the animals, the lungs were emphysematous. Free
bleeding in the stomach occurred in almost all the animals and was a con-
stant lesion. Hemorrhages were also observed on the visceral surface of
the stomach and intestines. In a few animals, petachiation was marked in
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the kidneys. Extensive hemorrhages were seen in the psoas muscles in many
of the chinchillas that died. Petechiation was also constantly found in
the cortex of the adrenals.
Kidneys. The kidneys were somewhat swollen and pale in appearance,
and some of them presented minute petechiation on the surface of the cortex,
which was particularly visible when the kidney was stripped. Greyish white
foci on the surface of the cortex, described in other animals were not ob-
served.
Liver. The liver was enlarged and mottled and somewhat congested.
Varied tints of yellowish green were present on the surface. In animals
without marked icterus, minute petechial hemorrhages in the substance of
the liver could be observed. The gall bladder appeared normal.
Spleen and lymph nodes were generally congested and enlarged.
Lungs. The most striking lesions in the lungs were ecchymotic
hemorrhages on the surface. In some, these hemorrhages were only a few
while in others, they were extensive and numerous. In a few animals the
lungs were emphysematous.
Microscopically, characteristic changes observed were focal interstitial
nephritis accompanied by degenerative changes in the tubules, cloudy swelling
and dissociation of liver cord cells and focal hemorrhages in the lung
perenchyma. Spleen was generally normal except for slight to moderate in-
crease in the hemosiderin pigment.
Kidneys. Kidney lesions were always consistent, though variable.
The tubular epithelium of the convoluted tubules revealed cloudy swelling
and various stages of degeneration and also regeneration. The cytoplasm
was very granular in some instances. The lumens of the tubules were filled
with granular debris and dead cells. An increased cellularity in the
collecting tubules with lymphocytes and nutrophils was especially striking
in some. Fatty degenerative changes in the corticomedullary area and less
changes in the distal portion of the calyces were observed. The glomerular
alterations were striking. A slight to moderate thickening of the basement
membrane, cloudy swelling and apparently hyalinization of the capsular
epithelium were observed. Varying degrees of dilation of the space within
the Bowman's capsule and varying amounts of albuminous precipitate in the
capsular spaces were observed.
Leptospires were numerous and typical and were found in the kidney
sections stained by silver impregnation technic.
The liver also presented evidence of degenerative changes. Marked
cloudy swelling and fatty infiltration were consistently observed. Dis-
sociation of liver cells was observed in many instances. Generalized
cellular infiltration or focal infiltration around the triads and large
vessels was significant.
Large number of leptospires were seen in silver impregnated sections
of the liver. These were observed between the liver cord cells.
Spleen. Except for considerable hemosiderin pigment in the spleen,
no other pathological lesions were seen in this organ. No organisms were
seen in sections stained by levaditi's method.
Leptospires were also observed in the lung sections.
Other organs and tissues did not present any significant pathological
lesions.
DISCUSSION
While these serological tests show contact with leptospira,
either acute or chronic, they do not evaluate the ability of
the animal to resist infection, especially a low descending or
vaccine titre which could be confused with a nonspecific reaction.
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So remarked Stoenner (107) regarding the serological tests in lepto-
spirosis. His statement could very well be appreciated from the innumerable
variations in titres of both vaccinated and control animals reported by
many workers (83) (38) (39) (37) in leptospiral immunology. Stoenner
attributed these variations to be mainly due to the bacterial cell concen-
tration in the antigen, the variability of dilution technic, growth time
and strain variation in the agglutination-lysis technic. It has been
demonstrated many a time in the study of other diseases too, that the
amount of circulating, agglutinating, precipitating or complement fixing
antibodies are not true measures of protection or immunity. The immunity
which develops in a syphilitic human patient is a unique example. It is
maintained at high level by continuous antigenic stimulation by a gm*i 1
,
number of organisms present in obscure areas of the body* It is well known
at present that animals can be infected with leptospirosis, experience
leptospiremia, develop renal foci and leptospiruria, all without showing a
marked febrile response or other clinical evidence. Clinical experience
with leptospiral vaccines has failed to give convincing results in some
cases. There was other evidence traced earlier that formalinized or other
chemically killed leptospiral vaccines have failed to prevent renal carrier
states in experimental animals (102) (28).
The relation of demonstrable antibody and effective immunity is far
from clear. There seems to be no corelation between serological titres and
effective immunity. The titres should not be taken too strictly as evidence
of immunity until it is clearly shown that such a co-relation exists.
Therefore, any evaluation of vaccine should necessarily include ade-
quate bacteriological demonstration of protection against infection in the
vaccinated animals, and susceptibility to infection in control animals.
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Failure to demonstrate organisms in the urine under microscope, or even
failure to isolate from the urine by animal inoculation from vaccinated
or control animals after challenge may not necessarily mean that the
vaccinated ones are protected. This is particularly true when it is
realized that quite often leptospiruria is intermittent or uncertain, and
that the knowledge of the carrier condition at present is inadequate.
To consider death or survival as a true measure of infection or pro-
tection by vaccination, none of the experimental animals were found to be
highly susceptible to leptospiral infection until recently. It is not
always easy to demonstrate infection or protection by other available
methods because of the possibility of the variations in technic and the
peculiarities of the disease as had been pointed out earlier.
Guinea pigs, hamsters, other experimental animals and cattle fre-
quently have a certain amount of natural resistance and survive inoculation
with virulent strains of leptospira, although the organisms might establish
foci of infection in certain areas of the body. The results of vaccination
and challenge in these animals therefore might be irregular and confusing.
The results of the present experiments have failed to indicate any
protection in the vaccinated chinchillas. The ma-Hm^ titre at the time of
challenge was only 1:10 in a few animals and none at all in the majority of
them. The low titres recorded may be nonspecific and may not be due to
vaccination. Clinically, all the vaccinees and controls had reacted to the
challenge similarly with typical clinical symptoms, and characteristic gross
and microscopic lesions.
As pointed earlier, it was interesting to observe more severe reactions
and early deaths in vaccinated than in control animals. This condition was
observed in both the experiments. In the second part, 87.5 per cent of the
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vaccinated animals died, while only 37.5 per cent of the controls died of
infection. The thermal reaction was more severe in the vaccinated than
in the control chinchillas and guinea pigs as well. Such a phenomena has
long been recognized in other diseases too. It was postulated earlier that
bacterial cell substances may act as sensitizing as well as immunizing agents.
This type of sensitivity to leptospiral bacterin has not been reported pre-
viously. Evidently, the bacterin injected in an attempt to immunize chin-
chillas had sensitized them to a subsequent infection, as could be expected,
an animal hypersensitive to an antigen, either bacteria or its cell sub-
stance, would be more susceptible to infection than a normal animal on
account of the enhanced toxic action of the bacterial antigen (114). The
question arises then, whether the exaggerated response of the tissues of
the hypersensitive chinchilla to the infective organism had any protective
action. For, it is known that such specific responses to the antigens of
the pathogens are sometimes mediated by detectable antibodies. From the
results of the present experiment, it is evident that this sensitized state
in chinchillas seems to be independent of the immune response.
In the determination of the ID 50, it was realized that the number of
animals used at the various dose levels was limited. However, looking at
the results in the control group of animsls (37.5 per cent deaths, 62.5 per
cent survivals) the method of determination was believed to be fairly satis-
factory.
The minimum infective dose (MID) of organisms in guinea pigs as re-
ported by Rengen and OkazeJd. (91) was 350 per inoculum. The results in this
study with guinea pigs indicate similar findings. Thermal reaction could
not be elicited in 33.3 per cent of the guinea pigs in the second experiment
with 250 organisms per dose (LD 50 for chinchilla). This indicates that the
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technic adopted for determination of the number of organiame per milliliter
compares well with those methods using bacterial counting chambers.
No significant changes in average daily weight gains in vaccinated and
control guinea pigs before and after challenge were observed (Tables 5-6).
Histopathological alterations consistently observed were hepatic
changes and nephritis. What appears as hyaline degeneration of Bowman's
capsule was observed in this study that was not described previously in
leptospirosis in domestic animals.
The pathogenesis of leptospirosis is not definitely known. The
mechanism of the bleeding tendency in this disease has not been clarified.
The probable factors as suggested by other workers (53) seem to be (a)
direct mechanical action of leptospires, (b) the effect of hepatic damage
and (c) a toxin or a hemolysin produced by the organisms in the tissues,
SUMMARY
This study indicated that chinchilla (Chinchilla Laniger) is a highly
susceptible animal to leptospirosis and the most suitable for the laboratory
studies of the disease.
The results of serological titrations did not indicate any appreciable
increase in serum titres in chinchilla and guinea pig following vaccination.
Clinical, bacteriological and pathological observations brought out
that vaccination with a leptospira pomona bacterin in chinchilla and guinea
pig did not afford adequate protection against an ID 50 challenge with the
organism.
Constant pathological lesions observed were hepatic, renal and spleenic
alterations, significant of these being the glomerular nephritis in some
animals leading to what appears as hyaline degeneration, which has not often
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been described in domestic animals*
The chinchilla and guinea pig were found to become hypersensitive
following vaccination to subsequent infection with Leptospira Pomona*
This type of hypersensitivity in animals due to leptospiral bacterin has
not been previously reported.
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> Results of challenging immunized chinchillas











t t Cultural t Died on the :
Thermal : Clinical • examina- : day post j
reaction : symptoms : tion : inoculation :















102.2 / contd. 5
102.4 / / 5
102.2 / / 5
102.8 / / 6
102.8 / / 5
104.2 / contd. 4
102.0 / / 5
102.2 / / 4
103.0 / / 5 .
101.8 / / 4
/
/
* Highest temperature recorded in degrees F.
** Fever, lassitude and partial or complete anorexia.
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Experiment #1
Table 2. Results of challenging control chinchillas with
Leptospira Pomona. 18 days post inoculation.
Controls.
I * t * j presence of
* » s Cultural t Died on the : leptospira
Chinchilla t Thermal : Clinical j examina- t day post : in tissue
number t reaction i symptoms t tion t inoculation : sections
1175 103.0 ,% / i /
1204 101.8 ,I contd. j y
1205 104.0 ,I contd. i y
1206 102.0 ,* / i> N.E.
120? 101.0 ;< / i* /
1208 102.0 |i / < i
1209 101.4 i' t i* /
1210 102.4 ;i / (i ?
1211 102.2 1t / i1 /
* Highest temperature recorded in degrees F.




Table 3. Results of challenging immunized guinea pigs with












7 106.0 - /
1175 105.6 - Contaminated
1176 103.8 - /
1177 105.0 - Contaminated
1178 104.6 - Contaminated




1182 105.4 *» /
1183 105.0 • Contaminated
1184 106.0 0t /
* Highest temperature recorded in degrees F.
** Contamination was due to serum used.
Experiment #1
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Table 4* Results of challenging control guinea pigs with













8 103.8 - Contaminated
1185 104*4 •* /
1186 105*8 - Contaminated
1187 104.6 «• Contaminated
1188 104.2 - Contaminated
1189 106.0 «• /
1190 104.6 - Contaminated
1191 105.2 •- Contaminated
1192 104.8 - Contaminated
1193 105.0 «• Contaminated
1199 103.8 «• Contaminated
* Highest temperature recorded in degrees F,
** Contamination was due to serum used.
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Experiment ffl
Table 5. Average gain per day in vaccinated guinea pigs (in grama).
Number of • Before challenge
20 days
i After challenge
animal : 1 10 days i 20 days : 30 days
J 3.9 6.2 3.0 4.7
1175 6.2 1.6 5.2 3.0
1176 4.7 5.8 7.5 6.0
1177 3.9 5.8 3.e 5.0
1178 4.7 2.5 3.8 2.5
1180 5.7 3.5 2.6 5.2
1181 4.2 2.5 5.0 2.5
1182 2.9 2.5 2.8 2.5
U83 4.1 1.7 2.6 3.8
1184 4.7 2.9 4.4 3.0
Average 4.5 3.5 4.0 3.8
50
Experiment #1
Table 6. Average gain per day in control guinea pigs (in grams).
Number of I t Before challenge 1
I 20 days i
r After challenge
animal I i 10 days t 20 days t 30 days
1185 4.2 2.6 4.4 1.7
1186 3.5 0.1 5.4 1.6
1187 5.6 5.4 3.3 5.2
1188 4.6 4.1 4.0 4.2
1189 3.1 4.4 2.7 3.5
1190 5.4 5.8 5.5 5.5
1191 2,8 2.0 4.5 3.3
1193 5.8 5.4 3.* 5.7
1199 5.7 7.2 2.3 6.2
Average 4.4 4.1 3.9 4.1
Experiment #2
Table 7* Summary of serological titrations in vaccinated
chinchillas. Single dose bacterin.
Number of t Preimmunization titre * Prechallenge titre
Chinchilla i It10 : I7j>0 : 1*250 * I*l(f~ i 1:50 * 1*250









Table 8. Summary of serological titrations in vaccinated
chinchillas. Double dose bacterin.
Number of i Preimmunlzation titre
Chinchilla t 1:10 t 1:50 : 1:250
a Prechallenge titre
















Table 9. Summary of serological titration* in control
chinchillas.
Number of i i Preiraiaunization titre : Prechallenge titre
Chinchilla i : 1:10 : 1:50 : 1:250 : 1:16 : 1:50 : 1:250
9402 t «• £ — —
9403 i «• «• f — —
9404 — — • t i
9405 i 6 «• / — —
9406 — - «• - <" «-
9407 « — - -
— —
9408 • «• — 4 -
9409 " — • - -
54
Experiment #2





: 1:10 : 1:50 : 1:250
:
:
Prechal 1 enge titre
1:10 : 1:50 : 1:250
181* mm m. «»
f — m
182 m — «• / mm -
183 — — • i
m% «»
184* — — m - - «•
187* «• • -
f /mm •
188 i t «» mm - m
189* t - 4 - •
190* 6 <» i m. »
191 - » / %t m}
192 — mm itl «• - mm
1» my. — m i - -
194 — - — t - •
* Double dose bacterin.
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Experiment §2
Table 11. Summary of serological titrations in control
guinea pigs.
Guinea pig : Prelmmunlaation titre i Preehallenge tltre
number : 1:10 1:50 1:250 i 1:10 t 1:50 : 1:250
171 .../.-
172 i - ...
173 / - - t
175 / ...
176 .-..--
177 ... •» . .
178 £ . . /







Table 12. Results of challenging immunized chinchillas





i t : Cultural
: Thermal t Clinical : examlna-
: reaction : symptoms : tion i
: t Presence of
t Died on the i leptospira
t day post t in tissue
: inoculation : sections
1 103.4 / / 9 t
4 102.8 / Contd. 10 /
5 102.6 / / 8 /
6 101.6 / / S /
7 102.4 / / 11 I.E.
8 102.0 / / 8 /
* 102.6 / / * /
n 102.2 r / * /
12 101.4 / / 8 /
33 102.4 / / 10 M.S.
H 101.0 / / 8 /
15 101.6 / / 8 /
* Highest temperature recorded in degrees F.




Table 13 • Results of challenging immunized chinchillas








Thermal : Clinical t examina-
reaction t symptoms : tion
: j
t Died on the :






16 103.0 / / 8 /
17 102.8 / Contd. 8 /
18 101.4 / / 9 -
19 102.0 / / 8 /
20 101.2 / / 9 i
21 102.6 / / 49 N.E.
22 101.8 / / Alive N.E.
23 102.4 / / 11 /
24 100.8 / Contd. Alive N.E.
25 101.8 / / 9 /
26 102.2 / / 8 N.E.
27 102.4 / / 7 /
* Highest temperature recorded in degrees F.




Table 14* Results of challenging control chinchillas
with Leptospira Pomona. 70 days post inocu-
lation.
I '% t I t Presence of
» « t Cultural : Died on the t leptospira
Chinchilla i Thermal x Clinical : examina- : day post t in tissue
number : reaction : symptoms t tion : inoculation t sections
9402 102.4 ii / Alive N.B.
9403 102.4 )1 / Alive M.1&.
9404 101.0 ,L Contd. Alive N.£.
9405 102.2 ;* / 23 H.E.
9406 102.6 j< / Alive M.S.
9407 101.4 7
f / 9 /
9408 101.4 f< / 49 /
9409 102.2 i\ / 16 ?
* Highest temperature recorded in degrees F.




Table 15* Results of challenging immunized guinea pigs










181* 1Q3.2 « /
182 102.4 - N.D.
183 104.8 - /
184* 103.2 «• /
187* 102.8 •• M.O.
188 102.4 « N.D.
189* 102.8 "( N,D.
190* 104.4 - /
in 104*2 » f
192 104.0 /
193* 103.8 m /
194 102.2 ss> N.D.




Table 16. Results of chaJJ.enging control guinea pigs
with Leptospira Pomona. 70 days post
inoculation.
Guinea pig : Thermal Clinical t Cultural
number j reaction symptoms i examination
: * : 1
171 103 .8 m t
172 103.4 - /
173 102.6 • N.D.
175 103.2 - N.D.
176 103.8 — /
177 104.8 • /
178 103.8 m /
179 103.6 » /
180 102.8 — N.D.
195 103.0 - N.D.
196 104.0 - /
198 104.0 • /
* Highest temperature recorded In degrees F.
N.D. Not done •
Experiment #2
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t Seg. t lymph, i
1
t Mono.
9402 2 2 f 39 49 1
9403 - 1 17 # 42 2
9404 1 - 10 4ft 40 1
9405 1 - • 52 39 -
9406 - J U 45 40 1
9408 X 2 1 90 43 1
9409 2 J 21 42 31 1
Average 1 i.5 10.8 44.8 40.5 1
Experiment #2
Table 18. Summary of differential blood counts in vaccinated
and control chinchillas before death.
61
Chinchilla
number Myelo I Juv. :
i
Stab. : Seg. t
1
Lymph. t Mono.
6# - 11 6 52 JO 1
** 2 12 4 42 Jt 1
11* 1 10 3 51 M 1
23** % 10 6 45 ar 1
9404*** - 8 8 ft 28 •»
9409*** 1 4 U 49 It 1
Average 0.8 9.5 6.3 49.5 31.6 0.8
* Single dose bacterin




EXPLANATION OF PLATE I
Vaccinated Chinchillas in Experiment #2, eight days post




EXPLANATION OF PLATE II
Vaccinated chinchilla in a moribund state in Experiment
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EXPLANATION OF PLATE VII
Lesions in chinchilla #3* Experiment #2, single dose
bacterin, died on the ninth day post inoculation showing
ecchymotic hemorrhages on (1) the surface of the lungs, (2)
the visceral surface of the stomach.
nPLATE VII
^A8^7-/
EXPLANATION OF PLATE VIII
Lesions In chinchilla #18, Experiment #2, double dose
bacterin,died on the ninth day post inoculation showing (X)
ecchymotic hemorrhages on the surface of lungs, (2) (3) petechial
hemorrhages on the cortex of the kidneys.
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EXPLANATION OF PLATE IX
Section of kidney showing degeneration of the epethelium
of the tubules. £ (Heootoxylin and eosin.)
PLATE IX
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KXFUMATXON OF PLATE X
Section of liver showing (1) (2) Leptospira Pomona,
(3) dissociation of liver cord cells. (Levaditi stain*)
PLATE X
78
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Human and animal infections with lepto spires have received increasing
attention during the past few years. Serological surveys and clinical find-
ings indicate that the disease is widespread in cattle and swine in the
United States and nearly 50 per cent of the cattle are estimated to have
had either clinical or subclinical infection with Leptospira Pomona. A
morbidity rate of 60 per cent and an annual loss of about one hundred
million dollars due to leptospirosis in cattle alone was estimated by the
United States Department of Agriculture in 1954. This has resulted in
continued research advocating various prophylactic programs and commercial
bacterins for the eradication or prevention of the spread of infection.
These bacterins have been claimed to produce satisfactory immunity although
field experiences and laboratory findings many times have not been con-
vincing. Consequently, this study was undertaken to evaluate the immuno-
logical response of a widely used commercial Leptospira Pomona bacterin in
laboratory animals.
Weil (124) was credited with having first described cases of
•leptospirosis 1 in 1886 followed by isolation of the etiologic agent
by Inado (54) in 1915. studies by various European, Australian and Japanese
workers followed by investigations in United States in recent years have re-
sulted in the present recognition of leptospirosis as a world wide public
health and livestock sanitary problem of great concern.
Epidemiologically, although rodents and swine are considered to be the
primary animal carriers, recent investigations have revealed a variety of
wild mammal hosts (1) (119) and many sylvatic leptospiral carriers.
Diagnosis and prophylaxis of leptospirosis present inumerable proble
due to the peculiarities of the disease and the fastidious nature of the
organisms.
Successful active immunization against leptospiral infections was
reported by various workers (54) (81) (126) (49) (123), while others hare
indicated a very low grade or no immunity to leptospiral bacterins in both
laboratory animals and field outbreaks, resulting in apparent clinical
infections or inapparent carrier states (102) (83) (20).
Finding the susceptibility of chinchilla (Chinchilla Laniger) as the
most suitable experimental animal tested to leptospirosis, these and guinea
pigs were used for the present study for comparative results. Groups of
animals were vaccinated with Leptospira Pomona bacterin and a similar
number of them were kept as controls. After allowing sufficient time for
the development of immunity, if any, the vaccinees and controls were
challenged with a known number of organisms from a virulent culture. In
the confirmatory test Median Lethal Dose (LDjq) for chinchilla was estimated
by a simple method and used for challenge. Besides, serum samples collected
before vaccination and challenge were titrated by agglutination-lysis test.
The virulence of the organism at the time of challenge was such that clinical
symptoms were consistently produced on inoculation in normal animals on the
third day resulting in death by the fifth day.
Thermal reaction, clinical symptoms, bacteriological evidence and
pathological lesions were considered as evidence of infection in vaccinated
as well as control animals in these experiments. Agglutination-lysis test
was made use of in the determination of immunity following vaccination.
This study indicated that chinchilla (Chinchilla Laniger) is the only
susceptible animal tested to leptospiral infections and suitable for labora-
tory studies of this disease.
The results of serological titrations, clinical, bacteriological and
pathological observations indicated that vaccination with Leptospira Pomona
bacterin in chinchilla and guinea pig did not afford adequate protection
against an LD«jq challenge.
Pathological lesions consistently observed in chinchilla were hepatic,
renal and spleenic, significant of these being the glomerular changes
leading to what appeared to be hyaline degeneration which has not often
been described in domestic animals.
The hypersensitivity following vaccination of chinchilla and guinea
pig to subsequent infection with Leptospira Pomona has not been reported
previously.
